@article{363c142800774cc2be4312ff7f948afe,
title = "Differential diagnosis of major depressive disorder versus bipolar disorder: Current status and best clinical practices",
author = "McIntyre, {Roger S.} and Mark Zimmerman and Goldberg, {Joseph F.} and First, {Michael B.}",
note = "Funding Information: or grants from private industries or nonprofit funds from Stanley Medical Research Institute and CIHR/GACD/ Chinese National Natural Research Foundation and has received consultant/speaker fees from Lundbeck, Janssen, Shire, Purdue, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, and Minerva. Dr Zimmerman has received consultant fees from Otsuka and Praxis Precision Medicines and has served on a speaker/advisory board for Alkermes. Dr Goldberg has received consultant fees from Lundbeck, Neurocrine, Otsuka, Sunovion, and WebMD and has served on speaker/advisory boards for Allergan, Neurocrine, Otsuka, Sunovion, and Takeda-Lundbeck. Dr First has received consultant fees as a member of the faculty of the Lundbeck International Neuroscience Foundation.",
year = "2019",
doi = "10.4088/JCP.OT18043AH2",
language = "English",
volume = "80",
pages = "15--24",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "3",
}